Markets:

Overview

News

Currencies

International

Treasuries

Spruce Biosciences, Inc. - Common Stock (NQ:SPRB)

79.99 -10.45 (-11.55%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Spruce Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings ↗

August 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

August 03, 2021

On Tuesday morning, 69 companies achieved new lows for the year. Intriguing Points: Las Vegas Sands (NYSE:LVS) was the largest firm by market cap to set a new 52-...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2021 ↗

July 19, 2021

Upgrades According to Colliers Securities, the prior rating for CyberArk Software Ltd (NASDAQ...

Via Benzinga

The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business ↗

August 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Spruce Biosciences Appoints Renowned Drug Developer Kirk Ways, M.D., Ph.D. to Board of Directors ↗

June 24, 2021

Dr. Ways’ Expertise in Late-Stage Clinical Development in Therapeutics Areas of High Unmet Medical Meet Supports Spruce’s Goal to Expand Portfolio of Indications for...

Via Benzinga

Spruce Biosciences Appoints Renowned Drug Developer Kirk Ways, M.D., Ph.D. to Board of Directors

June 24, 2021

From Spruce Biosciences, Inc.

Via Business Wire

48 Biggest Movers From Yesterday ↗

June 22, 2021

Gainers Lydall, Inc. (NYSE: LDL) shares jumped 85.4% to close at $61.72 on Monday after the company agreed to be acquired by Unifrax for $61.10 per share. New Concept Energy,...

Via Benzinga

The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal ↗

June 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

June 21, 2021

During Monday's morning session, 22 companies made new 52-week lows. Key Facts: China Life Insurance Co (NYSE:LFC) was the largest, in terms of market cap, to...

Via Benzinga

Spruce Biosciences Announces Publication of Phase 2 Results for Tildacerfont in Journal of Clinical Endocrinology and Metabolism

June 21, 2021

From Spruce Biosciences, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Friday ↗

June 18, 2021

Before 10 a.m. ET on Friday, 29 companies hit new 52-week lows. Noteables: The largest company in terms of market cap to set a new 52-week low was China Life Insurance Co...

Via Benzinga

The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs ↗

June 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme ↗

June 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) Alexion Pharmaceuticals,...

Via Benzinga

The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO ↗

June 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 15) Apellis Pharmaceuticals,...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

June 11, 2021

Friday morning, 5 companies reached new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Vertex Pharmaceuticals (NASDAQ:VRTX...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

June 04, 2021

On Friday morning, 7 companies hit new 52-week lows. Key Facts: The largest company by market cap to set a new 52-week low was TAL Education (NYSE:TAL). The company...

Via Benzinga

The Daily Biotech Pulse: Merck, AstraZeneca, Novartis Among Early Presenters At ASCO, Sanofi Strikes Breast Cancer Study Pact ↗

June 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 3) BioCryst Pharmaceuticals,...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

June 03, 2021

On Thursday morning, 11 companies achieved new lows for the year. Intriguing Points: TAL Education (NYSE:TAL) was the biggest company on a market cap basis to set a new 52...

Via Benzinga

The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs ↗

May 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 26) I-Mab (NASDAQ: IMAB)...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

May 26, 2021

Wednesday morning, 20 companies set new 52-week lows. Interesting Facts: The largest company in terms of market cap to set a new 52-week low was Ionis...

Via Benzinga

The Daily Biotech Pulse: Nabriva Jumps On Data, Larimar Wilts After Study Put On Hold, Travere To Delay Regulatory Filing ↗

May 26, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 25) ESSA Pharma Inc. (NASDAQ:...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

May 25, 2021

Tuesday's morning session saw 16 companies set new 52-week lows. Noteworthy Points: The largest company in terms of market cap to set a new 52-week low was...

Via Benzinga

Spruce Biosciences Presents Phase 2 Data for Tildacerfont in Adults with Congenital Adrenal Hyperplasia at 23rd European Congress of Endocrinology

May 24, 2021

From Spruce Biosciences, Inc.

Via Business Wire

Spruce Biosciences to Participate in the RBC Capital Markets Global Healthcare Conference

May 13, 2021

From Spruce Biosciences, Inc.

Via Business Wire

Spruce Biosciences Reports First Quarter 2021 Financial Results and Provides Corporate Updates

May 12, 2021

From Spruce Biosciences, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Spruce Biosciences, Inc. - Common Stock (NQ:SPRB)

All News about Spruce Biosciences, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today